A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions

References

• Lipinski CA. (2000). Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods, 44:235–249.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46:3–26.
   PubMed Web of Science ®Google Scholar
• Corrigan OI, Timoney RF. (1975). The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethiazide. J Pharm Pharmacol, 27:759–764.
   PubMed Web of Science ®Google Scholar
• Corrigan OI, Holohan EM. (1984). Amorphous spray-dried hydroflumethiazide–polyvinylpyrrolidone systems: physiochemical properties. J Pharm Pharmacol, 36:217–221.
   PubMed Web of Science ®Google Scholar
• Mosharraf M, Nyström C. (1999). The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs. Eur J Pharm Sci, 9:145–156.
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Bhardwaj V. (2008). Effect of amorphous content on dissolution characteristics of rifampicin. Drug Dev Ind Pharm, 34:642–649.
   PubMed Web of Science ®Google Scholar
• Kaushal AM, Gupta P, Bansal AK. (2004). Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst, 21:133–193.
   PubMedGoogle Scholar
• Zhang GGZ, Chen Y, Qiu Y. (2009). Crystalline and amorphous solids, in Developing Solid Oral Dosage Forms. Academic Press, San Diego, pp. 25–60.
   Google Scholar
• Van den Mooter G, Augustijns P, Blaton N, Kinget R. (1998). Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm, 164:67–80.
   Web of Science ®Google Scholar
• Corrigan OI, Crean AM. (2002). Comparative physicochemical properties of hydrocortisone–PVP composites prepared using supercritical carbon dioxide by the GAS anti-solvent recrystallization process, by coprecipitation and by spray drying. Int J Pharm, 245:75–82.
   PubMed Web of Science ®Google Scholar
• Andrews GP, Zhai H, Tipping S, Jones DS. (2009). Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene–polyoxypropylene solid dispersions. J Pharm Sci, 98:4545–4556.
   PubMed Web of Science ®Google Scholar
• Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P et al. (2001). Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci, 12:261–269.
   PubMed Web of Science ®Google Scholar
• Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. (2007). Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm, 336:22–34.
   PubMed Web of Science ®Google Scholar
• Betageri GV, Makarla KR. (1995). Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int J Pharm, 126:155–160.
   Web of Science ®Google Scholar
• Van den Mooter G, Weuts I, De Ridder T, Blaton N. (2006). Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int J Pharm, 316:1–6.
   PubMed Web of Science ®Google Scholar
• van Drooge DJ, Hinrichs WL, Wegman KA, Visser MR, Eissens AC, Frijlink HW. (2004). Solid dispersions based on inulin for the stabilisation and formulation of delta 9-tetrahydrocannabinol. Eur J Pharm Sci, 21:511–518.
   PubMed Web of Science ®Google Scholar
• Pandya P, Gattani S, Jain P, Khirwal L, Surana S. (2008). Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro–in vivo evaluation. AAPS Pharmscitech, 9:1247–1252.
   PubMed Web of Science ®Google Scholar
• Franks F. (2008). Freeze-Drying of Pharmaceuticals and Biopharmaceuticals: Principles and Practice. RSC publishing, Cambridge, pp. 72–88.
   Google Scholar
• Hancock BC, Dalton CR, Pikal MJ, Shamblin SL. (1998). A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials. Pharm Res, 15:762–767.
   PubMed Web of Science ®Google Scholar
• Couchman PR. (1978). Compositional variation of glass-transition temperatures. 2. Application of the thermodynamic theory to compatible polymer blends. Macromolecules, 11:1156–1161.
   Web of Science ®Google Scholar
• Couchman PR, Karasz FE. (1978). A classical thermodynamic discussion of the effect of composition on glass-transition temperatures. Macromolecules, 11:117–119.
   Web of Science ®Google Scholar
• Pinal R. (2008). Entropy of mixing and the glass transition of amorphous mixtures. Entropy, 10:207–223.
   Web of Science ®Google Scholar
• Forster A, Hempenstall J, Rades T. (2003). Comparison of the Gordon–Taylor and Couchman–Karasz equations for prediction of the glass transition temperature of glass solutions of drug and polyvinylpyrrolidone prepared by melt extrusion. Pharmazie, 58:838–839.
   PubMed Web of Science ®Google Scholar
• Tajber L, Corrigan OI, Healy AM. (2005). Physicochemical evaluation of PVP–thiazide diuretic interactions in co-spray-dried composites—analysis of glass transition composition relationships. Eur J Pharm Sci, 24:553–563.
   PubMed Web of Science ®Google Scholar
• Nair R, Nyamweya N, Gönen S, Martínez-Miranda LJ, Hoag SW. (2001). Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int J Pharm, 225:83–96.
   PubMed Web of Science ®Google Scholar
• Silverstein RM, Webster FX, Kiemle D. (2005). Spectrometric Identification of Organic Compounds, 7th edition. Wiley, New York.
   Google Scholar
• Kaushal AM, Chakraborti AK, Bansal AK. (2008). FTIR studies on differential intermolecular association in crystalline and amorphous states of structurally related non-steroidal anti-inflammatory drugs. Mol Pharm, 5:937–945.
   PubMed Web of Science ®Google Scholar
• Wen H. (2006). Adsorption at solid surfaces: pharmaceutical applications, in Encyclopedia of Pharmaceutical Technology, Swarbrick, J., ed. Informa Healthcare, New York, pp. 34–45.
   Google Scholar
• Mahlin D, Berggren J, Gelius U, Engström S, Alderborn G. (2006). The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles. Int J Pharm, 321:78–85.
   PubMedGoogle Scholar
• Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 17:397–404.
   PubMed Web of Science ®Google Scholar